Cancer Prevention News and Research

RSS

UTHealth researchers receive $1.5 million to increase HPV vaccine rates among minority youth

The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.

13 Mar 2017

New study shows how activation of innate immunity promotes tissue regeneration

Houston Methodist researchers have identified an immune pathway that promotes the formation of a cell that can develop into new tissues and organs.

9 Mar 2017

CPRIT awards $1.5 million grant to reduce burden of cervical cancer in West Texas

Navkiran Shokar, M.A., M.P.H, M.D., has received nearly $1.5 million from the Cancer Prevention and Research Institute of Texas to reduce the burden of cervical cancer in West Texas.

8 Mar 2017

Common cold virus can cause deadly pneumonia in transplant patients, study shows

The common cold is a major source of annoyance for most of us, but new research has found that the most prevalent respiratory infection can be far worse than a stuffy nose for one sector of the population — bone marrow transplant patients.

8 Mar 2017

Clinical study seeks to examine new combination therapy for treating AML patients

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

7 Mar 2017

Researchers issue first predictive risk model of colon, rectal cancer based on data from Spanish population

Researchers of the Colorectal Cancer research group of Bellvitge Biomedical Research Institute, led by Dr. Víctor Moreno, and linked to the Catalan Institute of Oncology, the University of Barcelona and the Epidemiology and Public Health CIBER, have issued the first predictive risk model of colon and rectal cancer based on Spanish data that combines genetic and lifestyle information.

7 Mar 2017

Isoflavone consumption linked to decrease in mortality for some breast cancer patients

An epidemiological analysis of data from more than 6,000 American and Canadian women with breast cancer finds that post-diagnosis consumption of foods containing isoflavones—estrogen-like compounds primarily found in soy food—is associated with a 21 percent decrease in all-cause mortality.

6 Mar 2017

Dietary soy products could be safe, beneficial for women diagnosed with breast cancer

New research indicates that dietary soy products are safe and even beneficial for women diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help resolve controversies over soy's potential link to breast cancer outcomes.

6 Mar 2017

New research emphasizes importance of skin cancer prevention and detection

On average, one person dies of melanoma, the deadliest form of skin cancer, every hour. Because this disease can affect anyone, everyone should take steps to reduce their risk and catch melanoma in its earliest stages, when it's most treatable.

3 Mar 2017

Attitude, lifestyle may play large role in incidence of skin cancer among Latinos

As the Hispanic population in the United States continues to grow, the incidence of skin cancer among this population is growing too. Moreover, Hispanic patients are more likely to be diagnosed with the disease in its more advanced stages, when it's more difficult to treat.

3 Mar 2017

New report reveals growing appetite for takeaways and ready meals among adults in the UK

New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).

3 Mar 2017

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Anyone who uses an employee badge to enter a building may understand how a protein called ENL opens new possibilities for treating acute myeloid leukemia (AML), a fast-growing cancer of bone marrow and blood cells and the second most common type of leukemia in children and adults.

2 Mar 2017

Specific dairy products may influence breast cancer risk in women, study shows

Specific dairy foods may influence breast cancer risk in women, although risk varies by the source of the dairy product, according to a study published online ahead of print in the journal Current Developments in Nutrition.

1 Mar 2017

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer.

25 Feb 2017

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.

22 Feb 2017

Cancer cells adapt nerve cell mechanisms to fuel aggressive tumor growth and spread

How we think and fall in love are controlled by lightning-fast electrochemical signals across synapses, the dynamic spaces between nerve cells. Until now, nobody knew that cancer cells can repurpose tools of neuronal communication to fuel aggressive tumor growth and spread.

21 Feb 2017

Drug given to reduce side effects of pain medication may facilitate gastrointestinal recovery after testicular cancer surgery

Post-operative recovery and length of hospital stay are critical things to consider when having major surgery. A drug commonly given to reduce the side effects of strong post-surgery pain medications has been found to reduce the length of hospital stays for patients who have undergone major gastrointestinal or bladder cancer procedures.

15 Feb 2017

Cancer Prevention News and Research

UTHealth researchers receive $1.5 million to increase HPV vaccine rates among minority youth

New study shows how activation of innate immunity promotes tissue regeneration

CPRIT awards $1.5 million grant to reduce burden of cervical cancer in West Texas

Common cold virus can cause deadly pneumonia in transplant patients, study shows

Clinical study seeks to examine new combination therapy for treating AML patients

Researchers issue first predictive risk model of colon, rectal cancer based on data from Spanish population

Isoflavone consumption linked to decrease in mortality for some breast cancer patients

Dietary soy products could be safe, beneficial for women diagnosed with breast cancer

New research emphasizes importance of skin cancer prevention and detection

Attitude, lifestyle may play large role in incidence of skin cancer among Latinos

New report reveals growing appetite for takeaways and ready meals among adults in the UK

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Specific dairy products may influence breast cancer risk in women, study shows

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Cancer cells adapt nerve cell mechanisms to fuel aggressive tumor growth and spread

Drug given to reduce side effects of pain medication may facilitate gastrointestinal recovery after testicular cancer surgery

New drug offers hope for patients with bladder cancer

Study: Decline in cancer cases may be linked to reduction in preventative health behaviors

Scientists identify vulnerabilities of highly aggressive pancreatic cancer cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News